2018
DOI: 10.2147/cmar.s171126
|View full text |Cite|
|
Sign up to set email alerts
|

Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway

Abstract: BackgroundUrothelial bladder cancer (UBC) is one of the most lethal urological malignancies in the world. Patients with UBC are routinely given chemotherapy which results in a median survival of 12-15 months. Nuclear-enriched abundant transcript 1 (NEAT1) functions as an oncogene and could be used as a therapeutic target for human UBC. However, the involvement of NEAT1 in doxorubicin (DOX) resistance of UBC has been poorly demonstrated.MethodsQuantitative Real-time PCR (qRT-PCR) was used to detect the expressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(15 citation statements)
references
References 39 publications
0
15
0
Order By: Relevance
“…In the DOX-resistant cell line, we could observe very significant downregulation of miR-214. Downregulation of this miR was also observed in the DOX-resistant urothelial bladder cancer tissues and cells lines [66]. Thus, the miR-214 can be a potential marker of DOX resistance.…”
Section: Discussionmentioning
confidence: 82%
“…In the DOX-resistant cell line, we could observe very significant downregulation of miR-214. Downregulation of this miR was also observed in the DOX-resistant urothelial bladder cancer tissues and cells lines [66]. Thus, the miR-214 can be a potential marker of DOX resistance.…”
Section: Discussionmentioning
confidence: 82%
“…Resveratrol therapeutic potential also includes its ability to treat BC resistant to numerous drugs either by re-sensitizing cancer cells to certain drug or by inhibiting cell growth by adopting alternative apoptosis route [ 94 – 97 ]. It re-sensitized cancer cells to doxorubicin in a dose-dependent manner [ 96 , 98 , 99 ]. It has a pro-apoptotic effect on taxol resistant BC cell lines by inhibiting cell growth beyond S-phase [ 100 ].…”
Section: Resveratrolmentioning
confidence: 99%
“…In DOX-resistant cell line we could observe very significant downregulation of miR-214. Downregulation of this miR was also observed in DOX-resistant urothelial bladder cancer tissues and cells lines [72]. Thus, the miR-214 can by a potential marker of DOX resistance.…”
Section: Discussionmentioning
confidence: 83%